What Are GLP-1 Weight Loss Medications
Tirzepatide operates as a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, a class of medication that has been increasingly used in the treatment of Type 2 diabetes and weight management
The average starting weight was 231 lb
While there's no single right way to taper, gradually reducing your dose with the guidance of your provider may help you avoid rapid weight regain and keep other benefits
Sanjay Gupta every Tuesday from the CNN Health team
In SURPASS-2, which compared tirzepatide to semaglutide (a GLP-1 receptor agonist) in patients taking metformin, tirzepatide 5 mg, 10 mg, and 15 mg doses achieved mean HbA1c reductions of 2.01%, 2.24%, and 2.30% respectively from baseline, compared to 1.86% with semaglutide 1 mg